Trial Profile
A Phase 1, Randomized, Double-Blind, Placebo-Controlled Dose Escalation Study to Assess the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Fidaxomicin in Healthy Male Japanese and Caucasian Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Dec 2023
Price :
$35
*
At a glance
- Drugs Fidaxomicin (Primary)
- Indications Bacterial infections
- Focus Pharmacokinetics
- Sponsors Astellas Pharma
- 01 Apr 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 27 Mar 2013 New trial record